Represent

Lobbying
Lobbying by Dialysis Patient Citizens

Lobbying Relationship

Client

Dialysis Patient Citizens

More records

Lobbying firm

Dialysis Patient Citizens

More records

Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age; Protect organ donors by urging passage of the living donor legislation; Protect dialysis patient access to charitable premium assistance; Support ESRD care coordination; Encourage support for improved kidney research and treatment; Support increased oversight of Organ Procurement Organizations; Support H.R. 5027 the Chronic Kidney Disease Improvement in Research and Treatment Act; Assist the Administration about prioritizing prevention of kidney disease and home dialysis; Support H.R. 6860 -The Restore Protections for Dialysis Patients Act to protect access to private insurance; Urge the Administration to provide adequate reimbursement to address the ongoing staffing shortages at dialysis centers; and Urge the Administration to provide appropriate reimbursement to increase dialysis patient access to new and innovative therapies. Urge passage of H.R. 5074 - The Kidney Patient Act that would delay the move of oral-only ESRD drugs into the ESRD bundle until 2033.

Duration: June 1, 2009 to present

General Issues: Medicare/Medicaid, Health Issues, Medical/Disease Research/Clinical Labs, Budget/Appropriations, Veterans

Spending: about $6,395,000 (But it's complicated. Here's why.)

Agencies lobbied since 2009: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), White House Office, Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Internal Revenue Service (IRS), Treasury - Dept of, Health Resources & Services Administration (HRSA), Veterans Affairs - Dept of (VA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS),

Bills mentioned

H.R.2644: Chronic Kidney Disease Improvement in Research and Treatment Act of 2017

Sponsor: Tom Marino (R-Pa.)

S.1890: Chronic Kidney Disease Improvement in Research and Treatment Act of 2017

Sponsor: Benjamin L. Cardin (D-Md.)

H.R.3976: Access to Marketplace Insurance Act

Sponsor: Kevin Cramer (R-N.D.)

H.R.3867: To amend title XVIII of the Social Security Act to create care...

Sponsor: Markwayne Mullin (R-Okla.)

H.R.5659: ESRD Choice Act of 2016

Sponsor: Jason Smith (R-Mo.)

H.R.5506: To amend title XVIII of the Social Security Act to establish a...

Sponsor: Todd Young (R-Ind.)

S.3090: Patient Access To Integrated-care, Empowerment, Nephrologists and...

Sponsor: Dean Heller (R-Nev.)

H.R.1130: Chronic Kidney Disease Improvement in Research and Treatment Act of 2015

Sponsor: Tom Marino (R-Pa.)

S.598: Chronic Kidney Disease Improvement in Research and Treatment Act of 2015

Sponsor: Benjamin L. Cardin (D-Md.)

H.R.698: HIV Organ Policy Equity Act

Sponsor: Lois Capps (D-Calif.)

S.330: HIV Organ Policy Equity Act

Sponsor: Barbara Boxer (D-Calif.)

S.323: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant...

Sponsor: Richard J. Durbin (D-Ill.)

H.R.1428: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant...

Sponsor: Michael C. Burgess (R-Texas)

H.R.4814: Chronic Kidney Disease Improvement in Research and Treatment Act of 2014

Sponsor: Tom Marino (R-Pa.)

H.R.5263: Living Donor Protection Act of 2014

Sponsor: Jerrold Nadler (D-N.Y.)

H.R.4188: Establishing Beneficiary Equity in the Hospital Readmission Program Act

Sponsor: Jim Renacci (R-Ohio)

S.2163: Kidney Disease Equitable Access, Prevention, and Research Act of 2012

Sponsor: Kent Conrad (D-N.D.)

H.R.6011: Kidney Disease Equitable Access, Prevention, and Research Act of 2012

Sponsor: John Lewis (D-Ga.)

S.1454: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant...

Sponsor: Richard J. Durbin (D-Ill.)

H.R.2969: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant...

Sponsor: Michael C. Burgess (R-Texas)

S.3271: Equal Access to Medicare Options Act of 2012

Sponsor: John Kerry (D-Mass.)

H.R.6482: To amend the Congressional Budget Act of 1974 respecting the scoring of...

Sponsor: Michael C. Burgess (R-Texas)

H.R.1458: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant...

Sponsor: Dave Camp (R-Mich.)

H.R.3200: America's Affordable Health Choices Act of 2009

Sponsor: John D. Dingell (D-Mich.)

S.1796: America's Healthy Future Act of 2009

Sponsor: Max Baucus (D-Mont.)

H.R.4143: Dialysis PATIENTS Demonstration Act of 2017

Sponsor: Jason Smith (R-Mo.)

S.2065: Dialysis PATIENTS Demonstration Act of 2017

Sponsor: Todd Young (R-Ind.)

H.R.8181: Jack Reynold’s Memory MediGap Expansion

Sponsor: Cynthia Axne (D-Iowa)

H.R.8254: BETTER Kidney Care Act

Sponsor: Earl Blumenauer (D-Ore.)

S.4574: Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER)...

Sponsor: Todd Young (R-Ind.)

H.R.5534: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant...

Sponsor: Ron Kind (D-Wis.)

S.3353: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant...

Sponsor: Bill Cassidy (R-La.)

H.R.1676: Jack Reynolds Memory Medigap Expansion Act

Sponsor: Cynthia Axne (D-Iowa)

H.R.1255: Living Donor Protection Act of 2021

Sponsor: Jerrold Nadler (D-N.Y.)

S.377: Living Donor Protection Act of 2021

Sponsor: Kirsten E. Gillibrand (D-N.Y.)

H.R.4065: Chronic Kidney Disease Improvement in Research and Treatment Act of 2021

Sponsor: Terri Sewell (D-Ala.)

S.1971: Chronic Kidney Disease Improvement in Research and Treatment Act of 2021

Sponsor: Benjamin L. Cardin (D-Md.)

H.R.4942: BETTER Kidney Care Act

Sponsor: Earl Blumenauer (D-Ore.)

S.2649: BETTER Kidney Care Act

Sponsor: Todd Young (R-Ind.)

H.R.8594: Restore Protections for Dialysis Patients Act

Sponsor: Yvette D. Clarke (D-N.Y.)

S.4750: Restore Protections for Dialysis Patients Act

Sponsor: Robert Menendez (D-N.J.)

H.R.5027: Chronic Kidney Disease Improvement in Research and Treatment Act of 2023

Sponsor: Carol Miller (R-W.Va.)

H.R.6860: Restore Protections for Dialysis Patients Act

Sponsor: Mike Kelly (R-Pa.)

H.R.5074: Kidney Patient Access to Technologically Innovative and Essential...

Sponsor: Buddy Carter (R-Ga.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist	Covered positions?
William Lennox	n/a
Hrant Jamgochian	n/a
Jackson Williams	n/a
Megan Beveridge	n/a
Carrie Lamb	n/a
Megan Hashbarger	n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

1st Quarter, 2024

Q1 Report

In Q1, Dialysis Patient Citizens had in-house lobbyists. The report was filed on April 22. Original Filing: 301574737.xml

Lobbying Issues

Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age; Protect organ donors by urging passage of the living donor legislation; Protect dialysis patient access to charitable premium assistance; Support ESRD care coordination; Encourage support for improved kidney research and treatment; Support increased oversight of Organ Procurement Organizations; Support H.R. 5027 the Chronic Kidney Disease Improvement in Research and Treatment Act; Assist the Administration about prioritizing prevention of kidney disease and home dialysis; Support H.R. 6860 -The Restore Protections for Dialysis Patients Act to protect access to private insurance; Urge the Administration to provide adequate reimbursement to address the ongoing staffing shortages at dialysis centers; and Urge the Administration to provide appropriate reimbursement to increase dialysis patient access to new and innovative therapies. Urge passage of H.R. 5074 - The Kidney Patient Act that would delay the move of oral-only ESRD drugs into the ESRD bundle until 2033.

Agencies Lobbied

Type of Issue

4th Quarter, 2023

Q4 Report

In Q4, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Jan. 19. Original Filing: 301533167.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2023

Q3 Report

In Q3, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Oct. 17, 2023. Original Filing: 301503358.xml

Lobbying Issues

Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age; Protect organ donors by urging passage of the living donor legislation; Protect dialysis patient access to charitable premium assistance; Support ESRD care coordination; Encourage support for improved kidney research and treatment; Support increased oversight of Organ Procurement Organizations; Support the Chronic Kidney Disease Legislation; Assist the Administration about prioritizing prevention of kidney disease and home dialysis; Urge Congress to protect access to private insurance; Urge the Administration to provide adequate reimbursement to address the ongoing staffing shortages at dialysis centers; and Urge the Administration to provide appropriate reimbursement to increase dialysis patient access to new and innovative therapies.

Agencies Lobbied

Type of Issue

2nd Quarter, 2023

Q2 Report

In Q2, Dialysis Patient Citizens had in-house lobbyists. The report was filed on July 19, 2023. Original Filing: 301481276.xml

Lobbying Issues

Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age; Protect organ donors by urging passage of the living donor legislation; Protect dialysis patient access to charitable premium assistance; Support ESRD care coordination; Encourage support for improved kidney research and treatment; Support increased oversight of Organ Procurement Organizations; Support the Chronic Kidney Disease Legislation; Assist the Administration about prioritizing prevention of kidney disease and home dialysis; Urge Congress to protect access to private insurance; Urge the Administration to provide adequate reimbursement to address the ongoing staffing shortages at dialysis centers; and Urge the Administration to provide appropriate reimbursement to increase dialysis patient access to new and innovative therapies.

Agencies Lobbied

Type of Issue

1st Quarter, 2023

Q1 Report

In Q1, Dialysis Patient Citizens had in-house lobbyists. The report was filed on April 20, 2023. Original Filing: 301462012.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2022

Q4 Report

In Q4, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Jan. 18, 2023. Original Filing: 301431425.xml

Lobbying Issues

Assist the Administration during Covid-19 epidemic on how to help and protect dialysis patients; Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age - (H.R. 1676) - The Jack Reynolds Memorial Medigap Expansion Bill; Protect organ donors by urging passage of the Living Donor Protection Act of 2021 (H.R. 1255/S. 377); Protect dialysis patient access to charitable premium assistance; Ensure ESRD patients retain access to private insurance; Support ESRD care coordination - The BETTER Kidney Care Bill (H.R. 4942/S. 2649); Encourage support for improved kidney research and treatment; Support increased oversight of Organ Procurement Organizations; Support the Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 4065/S. 1971); Assist the Administration about Prioritizing Prevention, Home Dialysis; and Urge Congress to protect access to private insurance H.R. 8594/S. 4750 - The Restore Protections for Dialysis Patients Act.

Agencies Lobbied

Type of Issue

3rd Quarter, 2022

Q3 Report

In Q3, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Oct. 25, 2022. Original Filing: 301421117.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2022

Q2 Report

In Q2, Dialysis Patient Citizens had in-house lobbyists. The report was filed on July 20, 2022. Original Filing: 301391561.xml

Lobbying Issues

Assist the Administration during Covid-19 epidemic on how to help and protect dialysis patients; Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age - (H.R. 1676) - The Jack Reynolds Memorial Medigap Expansion Bill; Protect organ donors by urging passage of the Living Donor Protection Act of 2021 (H.R. 1255/S. 377); Protect dialysis patient access to charitable premium assistance; Ensure ESRD patients retain access to private insurance; Support ESRD care coordination - The BETTER Kidney Care Bill (H.R. 4942/S. 2649); Encourage support for improved kidney research and treatment; Support increased oversight of Organ Procurement Organizations; Support the Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 4065/S. 1971); and Assist the Administration about Prioritizing Prevention, Home Dialysis.

Agencies Lobbied

Type of Issue

1st Quarter, 2022

Q1 Report

In Q1, Dialysis Patient Citizens had in-house lobbyists. The report was filed on April 20, 2022. Original Filing: 301364646.xml

Lobbying Issues

Assist the Administration during Covid-19 epidemic on how to help and protect dialysis patients; Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age - (H.R. 1676) - The Jack Reynolds Memorial Medigap Expansion Bill; Protect organ donors by urging passage of the Living Donor Protection Act of 2021 (H.R. 1255/S. 377); Protect dialysis patient access to charitable premium assistance; Ensure ESRD patients retain access to private insurance; Support ESRD care coordination - The BETTER Kidney Care Bill (H.R. 4942/S. 2649); Encourage support for improved kidney research and treatment; Support increased oversight of Organ Procurement Organizations; Support the Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 4065/S. 1971); and Assist the Administration about Prioritizing Prevention, Home Dialysis.

Agencies Lobbied

Type of Issue

4th Quarter, 2021

Q4 Report

In Q4, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Jan. 27, 2022. Original Filing: 301339962.xml

Lobbying Issues

Assist the Administration during Covid-19 epidemic on how to help and protect dialysis patients; Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age - (H.R. 1676) - The Jack Reynolds Memorial Medigap Expansion Bill; Protect organ donors by urging passage of the Living Donor Protection Act of 2021 (H.R. 1255/S. 377); Protect dialysis patient access to charitable premium assistance; Ensure ESRD patients retain access to private insurance; Support ESRD care coordination - The BETTER Kidney Care Bill (H.R. 4942/S. 2649); Encourage support for improved kidney research and treatment; Support increased oversight of Organ Procurement Organizations; Support the Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 4065/S. 1971); and Assist the Administration about Prioritizing Prevention, Home Dialysis.

Agencies Lobbied

Type of Issue

3rd Quarter, 2021

Q3 Report

In Q3, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Oct. 19, 2021. Original Filing: 301303099.xml

Lobbying Issues

Assist the Administration during Covid-19 epidemic on how to help and protect dialysis patients; Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age - (H.R. 1676) - The Jack Reynolds Memorial Medigap Expansion Bill; Protect organ donors by urging passage of the Living Donor Protection Act of 2021 (H.R. 1255/S. 377); Protect dialysis patient access to charitable premium assistance; Ensure ESRD patients retain access to private insurance; Support ESRD care coordination - The BETTER Kidney Care Bill (H.R. 4942/S. 2649); Encourage support for improved kidney research and treatment; Support increased oversight of Organ Procurement Organizations; Support the Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 4065/S. 1971); and Assist the Administration about Prioritizing Prevention, Home Dialysis.

Agencies Lobbied

Type of Issue

2nd Quarter, 2021

Q2 Report

In Q2, Dialysis Patient Citizens had in-house lobbyists. The report was filed on July 18, 2021. Original Filing: 301279755.xml

Lobbying Issues

Assist the Administration during Covid-19 epidemic on how to help and protect dialysis patients; Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age - (H.R. 1676) - The Jack Reynolds Memorial Medigap Expansion Bill; Protect organ donors by urging passage of the Living Donor Protection Act of 2021 (H.R. 1255/S. 377); Protect dialysis patient access to charitable premium assistance; Ensure ESRD patients retain access to private insurance; Support ESRD care coordination - The BETTER Kidney Care Bill; Encourage support for improved kidney research and treatment; Support increased oversight of Organ Procurement Organizations; Support the Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 4065/S. 1971); and Assist the Administration about Prioritizing Prevention, Home Dialysis.

Agencies Lobbied

Type of Issue

1st Quarter, 2021

Q1 Report

In Q1, Dialysis Patient Citizens had in-house lobbyists. The report was filed on April 11, 2021. Original Filing: 301251637.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2020

Q4 Report

In Q4, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Jan. 8, 2021. Original Filing: 301229271.xml

Lobbying Issues

Assist the Administration during Covid-19 epidemic on how to help and protect dialysis patients; Advise the Administration on implementation of Medicare Advantage coverage for dialysis patients starting in 2021, which has since resulted in litigation over a final regulation that is reducing patient access in violation of anti-discrimination laws and was enacted in violation of the Administrative Procedures Act; Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age - (H.R. 8181) - The Jack Reynolds Memorial Medigap Expansion Bill; Protect dialysis patient access to charitable premium assistance; Ensure ESRD patients retain access to private insurance; Support ESRD care coordination - (H.R. 8254/S. 4574) - The BETTER Kidney Care Bill; Encourage support for improved kidney research and treatment; Support increased oversight of Organ Procurement Organizations; Assist the Administration about Prioritizing Prevention, Home Dialysis, and Transplant; and Support for extending access to immunosuppressive drugs for transplant patients - (H.R. 5534/S. 3353) - The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act.

Agencies Lobbied

Type of Issue

3rd Quarter, 2020

Q3 Report

In Q3, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Oct. 12, 2020. Original Filing: 301208867.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2020

Q2 Report

In Q2, Dialysis Patient Citizens had in-house lobbyists. The report was filed on July 30, 2020. Original Filing: 301204237.xml

Lobbying Issues

Assist the Administration during Covid-19 epidemic on how to help and protect dialysis patients; Advise the Administration on implementation of Medicare Advantage coverage for dialysis patients starting in 2021, which has since resulted in litigation over a final regulation that is reducing patient access in violation of anti-discrimination laws and was enacted in violation of the Administrative Procedures Act; Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age; Protect dialysis patient access to charitable premium assistance; Ensure ESRD patients retain access to private insurance; Support ESRD care coordination; Encourage support for improved kidney research and treatment; Support increased oversight of Organ Procurement Organizations; Assist the Administration about Prioritizing Prevention, Home Dialysis, and Transplant; and Support for extending access to immunosuppressive drugs for transplant patients.

Agencies Lobbied

Type of Issue

1st Quarter, 2020

Q1 Report

In Q1, Dialysis Patient Citizens had in-house lobbyists. The report was filed on May 6, 2020. Original Filing: 301182334.xml

Lobbying Issues

Assist the Administration during Covid-19 epidemic on how to help and protect dialysis patients; Advise the Administration on implementation of Medicare Advantage coverage for dialysis patients starting in 2021; Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age; Protect dialysis patient access to charitable premium assistance; Ensure ESRD patients retain access to private insurance; Support ESRD care coordination; Encourage support for improved kidney research and treatment; Support increased oversight of Organ Procurement Organizations; Assist the Administration about Prioritizing Prevention, Home Dialysis, and Transplant; and Support for extending access to immunosuppressive drugs for transplant patients.

Agencies Lobbied

Type of Issue

4th Quarter, 2019

Q4 Report

In Q4, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Jan. 22, 2020. Original Filing: 301129728.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2019

Q3 Report

In Q3, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Oct. 21, 2019. Original Filing: 301076268.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2019

Q2 Report

In Q2, Dialysis Patient Citizens had in-house lobbyists. The report was filed on July 15, 2019. Original Filing: 301045667.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2019

Q1 Report

In Q1, Dialysis Patient Citizens had in-house lobbyists. The report was filed on May 7, 2019. Original Filing: 301040399.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2018

Q4 Report

In Q4, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Jan. 25, 2019. Original Filing: 301018908.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2018

Q3 Report

In Q3, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Oct. 16, 2018. Original Filing: 300986441.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2018

Q2 Report

In Q2, Dialysis Patient Citizens had in-house lobbyists. The report was filed on July 18, 2018. Original Filing: 300967879.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2018

Q1 Report

In Q1, Dialysis Patient Citizens had in-house lobbyists. The report was filed on April 17, 2018. Original Filing: 300945711.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2017

Q4 Report

In Q4, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Jan. 18, 2018. Original Filing: 300927244.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2017

Q3 Report

In Q3, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Oct. 17, 2017. Original Filing: 300906008.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2017

Q2 Report

In Q2, Dialysis Patient Citizens had in-house lobbyists. The report was filed on July 19, 2017. Original Filing: 300890216.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2017

Q1 Report

In Q1, Dialysis Patient Citizens had in-house lobbyists. The report was filed on April 10, 2017. Original Filing: 300863456.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2016

Q4 Report

In Q4, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Jan. 18, 2017. Original Filing: 300848390.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2016

Q3 Report

In Q3, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Oct. 17, 2016. Original Filing: 300829443.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2016

Q2 Report

In Q2, Dialysis Patient Citizens had in-house lobbyists. The report was filed on July 19, 2016. Original Filing: 300813147.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2016

Q1 Report

In Q1, Dialysis Patient Citizens had in-house lobbyists. The report was filed on April 18, 2016. Original Filing: 300793556.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2015

Q4 Report

In Q4, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Jan. 19, 2016. Original Filing: 300777244.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2015

Q3 Report

In Q3, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Nov. 3, 2015. Original Filing: 300767121.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2015

Q2 Report

In Q2, Dialysis Patient Citizens had in-house lobbyists. The report was filed on July 20, 2015. Original Filing: 300745300.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2015

Q1 Report

In Q1, Dialysis Patient Citizens had in-house lobbyists. The report was filed on April 8, 2015. Original Filing: 300713416.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2014

Q4 Report

In Q4, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Jan. 14, 2015. Original Filing: 300695547.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2014

Q3 Report

In Q3, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Oct. 7, 2014. Original Filing: 300674136.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2014

Q2 Report

In Q2, Dialysis Patient Citizens had in-house lobbyists. The report was filed on July 15, 2014. Original Filing: 300657188.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2014

Q1 Report

In Q1, Dialysis Patient Citizens had in-house lobbyists. The report was filed on May 6, 2014. Original Filing: 300651236.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2013

Q4 Report

In Q4, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Jan. 17, 2014. Original Filing: 300618852.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2013

Q3 Report

In Q3, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Oct. 24, 2013. Original Filing: 300608336.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2013

Amendment

Dialysis Patient Citizens amended a lobbying report for in-house lobbying in Q22013 on July 5, 2016 Original Filing: 300806634.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2013

Q2 Report

In Q2, Dialysis Patient Citizens had in-house lobbyists. The report was filed on July 19, 2013. Original Filing: 300578248.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2013

Q1 Report

In Q1, Dialysis Patient Citizens had in-house lobbyists. The report was filed on April 15, 2013. Original Filing: 300549738.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2012

Q4 Report

In Q4, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Jan. 14, 2013. Original Filing: 300528343.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2012

Q3 Report

In Q3, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Oct. 18, 2012. Original Filing: 300511907.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2012

Q2 Report

In Q2, Dialysis Patient Citizens had in-house lobbyists. The report was filed on July 16, 2012. Original Filing: 300484985.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2012

Q1 Report

In Q1, Dialysis Patient Citizens had in-house lobbyists. The report was filed on April 18, 2012. Original Filing: 300464067.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2011

Q4 Report

In Q4, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Jan. 18, 2012. Original Filing: 300440416.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2011

Q3 Report

In Q3, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Oct. 19, 2011. Original Filing: 300422369.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2011

Q2 Report

In Q2, Dialysis Patient Citizens had in-house lobbyists. The report was filed on July 19, 2011. Original Filing: 300395953.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2011

Q1 Report

4th Quarter, 2010

Q4 Report

3rd Quarter, 2010

Q3 Report

In Q3, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Oct. 20, 2010. Original Filing: 300324805.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2010

Q2 Report

In Q2, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Oct. 4, 2010. Original Filing: 300308705.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2010

Q1 Report

In Q1, Dialysis Patient Citizens had in-house lobbyists. The report was filed on April 20, 2010. Original Filing: 300273964.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2009

Q4 Report

In Q4, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Jan. 20, 2010. Original Filing: 300248589.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2009

Q3 Report

In Q3, Dialysis Patient Citizens had in-house lobbyists. The report was filed on Oct. 20, 2009. Original Filing: 300218264.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2009

Registration

2nd Quarter, 2009

Q2 Report

In Q2, Dialysis Patient Citizens had in-house lobbyists. The report was filed on July 20, 2009. Original Filing: 300193704.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Legislators

Bills

Statements

Lobbying

Travel

Lobbyists

Disclosures Filed